* RedHill Biopharma (NASDAQ:RDHL [https://seekingalpha.com/symbol/RDHL]) on Monday announced that it has received its first Talicia ex-U.S. sales milestone, royalties and other payments totaling approximately $1.1 million.
* Talicia is the first-line therapy prescribed by U.S. gastroenterologists for treatment of H. pylori infection.
* RDHL +19.85% premarket to $1.63.
* Source: Press Release [https://seekingalpha.com/pr/20203737-redhill-received-talicia-licensing-payments-totaling-1_1-million]
MORE ON REDHILL
* Financial information for RedHill [https://seekingalpha.com/symbol/RDHL/income-statement]
RedHill received Talicia licensing payments totaling $1.1 million
Published 2 months ago
Aug 18, 2025 at 1:20 PM
Neutral
Auto